CORRECTED: Mylan's Inequitable Conduct Claim Axed In Vytorin IP Suit

By Erin Marie Daly · May 19, 2011, 1:51 PM EDT

Schering Corp. on Tuesday won the dismissal of an inequitable conduct counterclaim by Mylan Pharmaceuticals Inc. in a ruling in Schering's lawsuit accusing the generic-drug maker of infringing its patents on...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

MERCK SHARP & DOHME CORP. et al v. MYLAN PHARMACEUTICALS INC. et al

Case Number

Court

New Jersey

Nature of Suit

Patent

Date Filed

December 16, 2009

Recent Articles By Erin

May 19, 2011
Genentech Sues Apotex Over Generic Valcyte
May 18, 2011
Firms, Experts Allowed To Stay In AndroGel MDL
May 10, 2011
Pharmacies Attack $68B Pfizer-Wyeth Deal In 9th Circ.
May 03, 2011
2nd Circ. Rejects Nurses Review Of Class Cert. Denial
April 27, 2011
Genzyme Sues Over Endo's Bid To Sell Generic Renvela
April 27, 2011
Asahi, Actelion Throw Final Punches In Fasudil IP Row
April 20, 2011
Novartis Targets Teva Over Myfortic Patents
April 13, 2011
HGS Fires Round 2 At Genentech Over Lupus Drug IP
April 13, 2011
MetroPlus, HHC Evade State Claims In OT Action
April 08, 2011
UK Court Shutters Merck's Cosopt Patent Fight